PLI PLUS Title Details

Skip to main content

Create Account
Training Center
Contact Us

Questions? Comments?
Contact us.

Email: PLUS@pli.edu
Phone: 877.900.5291
PLI.edu
SIGN IN

Search
Browse
My Bookshelf
My History

< Back To Results

1 in 1 results

Previous Result
Next Result

Book Cover Image

Developments in Pharmaceutical and Biotech Patent Law 2016

Chair(s): David K. Barr, Daniel L. Reisner

Practice Area: Biotechnology, Health care, Intellectual property, Life sciences, Litigation, Patent litigation, Patents, Pharmaceuticals

Published: Dec 2016 i Other versions can be found in the Related Items tab.
ISBN: 9781402427824
PLI Item #: 150243
CHB Spine #: G1296

This version is not current.
Click here for the most recent version.

Email
Print
Add To Bookshelf
Permalink

Table of Contents
Related Items

Select All

Front Matter
Faculty Bios
Table of Contents
Chapter 1. Willfulness: A Return to the Bad Old Days (2016)
Chapter 2. Chapter 14 Biologic and Biosimilar Drug Products, prepublication revision, PLI Legal Treatise, Pharmaceutical and Biotech Patent Law
Chapter 3. Local Rules of Civil Practice and Procedure of the United States District Court for the District of Delaware (August 1, 2016)
Chapter 4. L. Civ. R. 9.3—Local Patent Rules
Chapter 5. Sample Judge Waldor Pretrial Scheduling Order
Chapter 6. Sample Appendix A to Joint Discovery Plan
Chapter 7. Sample Judge Arpert Joint Discovery Plan
Chapter 8. Sample Judge Goodman Joint Discovery Plan and Proposed Scheduling Order
Chapter 9. Injunctive Relief in Pharmaceutical Patent Cases under the “Causal Nexus” Test of Apple v. Samsung (August 24, 2016)
Chapter 10. Section 101: Patentable Subject Matter in the Aftermath of Myriad and Mayo
Chapter 11. Learning to Sail Outside the Safe Harbor: Pleading Direct Patent Infringement after Abrogation of Rule 84 and Form 18
Index

About Us

All Contents Copyright © 1996-2021 Practising Law Institute. About PLI PLUS PLI Librarian Blog PLI PLUS app Privacy Policy Terms Of Use
Continuing Legal Education since 1933.